Prime Therapeutics has acquired 1 company, including 1 in the last 5 years.
Prime Therapeutics’ largest acquisition to date was in 2022, when it acquired Magellan Rx Management for $1.4B. Prime Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
2900 Ames Crossing Road,
Eagan, Minnesota
55121
United States,
(800) 858-0723
www.primetherapeutics.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-05-05 |
Magellan Rx · Life Science
Phoenix, Arizona · www1.magellanrx.com Magellan Rx is a next-generation pharmacy organization that is delivering meaningful solutions to the people we serve. As pioneers in specialty drug management, industry leaders in Medicaid pharmacy programs, and innovators in pharmacy benefit management, Magellan Rx partners with our customers and members to deliver a best-in-class healthcare experience. Magellan Rx is based in Phoenix, Arizona. |
1,350 | Divestiture |
Prime Therapeutics
|
Centene
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
